目次

Executive Summary
Market overview

Market Landscape
Market ecosystem
Value chain analysis

Market Sizing
Market definition
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
Five forces summary
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by Product
Market segments
Comparison by Product
E-cigarette - Market size and forecast 2020-2025
NRT - Market size and forecast 2020-2025
Drug therapy - Market size and forecast 2020-2025
Market opportunity by Product

Customer landscape

Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
APAC - Market size and forecast 2020-2025
South America - Market size and forecast 2020-2025
MEA - Market size and forecast 2020-2025
Key leading countries
Market opportunity By Geographical Landscape
Market drivers
Market challenges
Market trends

Vendor Landscape
Overview
Vendor landscape
Landscape disruption

Vendor Analysis
Vendors covered
Market positioning of vendors
British American Tobacco Plc
Cipla Inc.
Dr. Reddys Laboratories Ltd.
GlaxoSmithKline Plc
Imperial Brands Plc
Japan Tobacco Inc.
Johnson and Johnson Inc.
JUUL Labs Inc.
Pfizer Inc.
Philip Morris International Inc.

Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations

Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2020 - 2025 ($ million)
13: Global market: Year-over-year growth 2020 - 2025 (%)
14: Five forces analysis 2020 & 2025
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2020
21: Product - Market share 2020-2025 (%)
22: Comparison by Product
23: E-cigarette - Market size and forecast 2020-2025 ($ million)
24: E-cigarette - Year-over-year growth 2020-2025 (%)
25: NRT - Market size and forecast 2020-2025 ($ million)
26: NRT - Year-over-year growth 2020-2025 (%)
27: Drug therapy - Market size and forecast 2020-2025 ($ million)
28: Drug therapy - Year-over-year growth 2020-2025 (%)
29: Market opportunity by Product
30: Customer landscape
31: Market share By Geographical Landscape 2020-2025 (%)
32: Geographic comparison
33: North America - Market size and forecast 2020-2025 ($ million)
34: North America - Year-over-year growth 2020-2025 (%)
35: Europe - Market size and forecast 2020-2025 ($ million)
36: Europe - Year-over-year growth 2020-2025 (%)
37: APAC - Market size and forecast 2020-2025 ($ million)
38: APAC - Year-over-year growth 2020-2025 (%)
39: South America - Market size and forecast 2020-2025 ($ million)
40: South America - Year-over-year growth 2020-2025 (%)
41: MEA - Market size and forecast 2020-2025 ($ million)
42: MEA - Year-over-year growth 2020-2025 (%)
43: Key leading countries
44: Market opportunity By Geographical Landscape ($ million)
45: Impact of drivers and challenges
46: Vendor landscape
47: Landscape disruption
48: Industry risks
49: Vendors covered
50: Market positioning of vendors
51: British American Tobacco Plc - Overview
52: British American Tobacco Plc - Business segments
53: British American Tobacco Plc - Key offerings
54: British American Tobacco Plc - Key customers
55: British American Tobacco Plc - Segment focus
56: Cipla Inc. - Overview
57: Cipla Inc. - Business segments
58: Cipla Inc. - Key offerings
59: Cipla Inc. - Key customers
60: Cipla Inc. - Segment focus
61: Dr. Reddys Laboratories Ltd. - Overview
62: Dr. Reddys Laboratories Ltd. - Business segments
63: Dr. Reddys Laboratories Ltd. - Key offerings
64: Dr. Reddys Laboratories Ltd. - Key customers
65: Dr. Reddys Laboratories Ltd. - Segment focus
66: GlaxoSmithKline Plc - Overview
67: GlaxoSmithKline Plc - Business segments
68: GlaxoSmithKline Plc - Key offerings
69: GlaxoSmithKline Plc - Key customers
70: GlaxoSmithKline Plc - Segment focus
71: Imperial Brands Plc - Overview
72: Imperial Brands Plc - Business segments
73: Imperial Brands Plc - Key offerings
74: Imperial Brands Plc - Key customers
75: Imperial Brands Plc - Segment focus
76: Japan Tobacco Inc. - Overview
77: Japan Tobacco Inc. - Business segments
78: Japan Tobacco Inc. - Key offerings
79: Japan Tobacco Inc. - Key customers
80: Japan Tobacco Inc. - Segment focus
81: Johnson and Johnson Inc. - Overview
82: Johnson and Johnson Inc. - Business segments
83: Johnson and Johnson Inc. - Key offerings
84: Johnson and Johnson Inc. - Key customers
85: Johnson and Johnson Inc. - Segment focus
86: JUUL Labs Inc. - Overview
87: JUUL Labs Inc. - Product and service
88: JUUL Labs Inc. - Key offerings
89: JUUL Labs Inc. - Key customers
90: JUUL Labs Inc. - Segment focus
91: Pfizer Inc. - Overview
92: Pfizer Inc. - Business segments
93: Pfizer Inc. - Key offerings
94: Pfizer Inc. - Key customers
95: Pfizer Inc. - Segment focus
96: Philip Morris International Inc. - Overview
97: Philip Morris International Inc. - Business segments
98: Philip Morris International Inc. - Key offerings
99: Philip Morris International Inc. - Key customers
100: Philip Morris International Inc. - Segment focus
101: Currency conversion rates for US$
102: Research Methodology
103: Validation techniques employed for market sizing
104: Information sources
105: List of abbreviations